Brief: 10X Genomics Q3 Revenue USD 153.6 Million Vs. IBES Estimate USD 151.3 Million
02/11/2023 20:05
Nov 02 (Reuters) - 10X Genomics Q3 operating income USD -94.8 million. * Q3 gross margin 62% * Q3 net income USD -93 million * outlook FY revenue USD 610-625 million
Recent news on 10x Genomics
See all newsBrief: 10X Genomics Announces New Collaboration To Advance Single Cell And Spatial Applications Across Solid Tumors And Blood Cancers
U.S. RESEARCH ROUNDUP-Autodesk, Hubspot, Oracle
Delaware jury finds Parse infringed three genetic-sequencing patents (updated)
Qiagen owes 10x, Roche $4.8 million for infringing patents, U.S. jury says
Brief: 10X Genomics Wins Patent Infringement Verdict Against Parse Biosciences